Consistently, it has been observed that the CCL2-CCR2 (C-C chemokine receptor type 2) axis promotes the establishment of inflammatory monocytes to the metastatic site, where they will transition into metastatic-associated macrophages (MAMs) and will enhance the extravasation and survival of metastasis-resident cancer cells (160). Here, CCR2 is linked to cancer.